Skip to Main Content

Meet Dr. Terri Parker

June 21, 2021

Dr. Terri Parker discusses what drew her to the field of hematology, how she uses a multidisciplinary approach to care for her patients, and the importance of clinical trials.

ID
6737

Transcript

  • 00:00My name is Terry Parker and I'm an
  • 00:03assistant professor of medicine.
  • 00:05In this section of hematology.
  • 00:06So in medical school and an
  • 00:08internal medicine residency,
  • 00:09I was always drawn to the
  • 00:12human to logical malignancies.
  • 00:13The research in the field was
  • 00:15rapidly expanding and very exciting,
  • 00:17and the patients had these amazing
  • 00:20relationships with their physicians,
  • 00:21many spanning years, and all of this had.
  • 00:25Led to my decision to specialize
  • 00:27in haematological malignancies,
  • 00:28specifically plasma cell disorders
  • 00:29when patients come from the first
  • 00:31appointment with any physician,
  • 00:33especially when discussing a
  • 00:34possible or new diagnosis of cancer,
  • 00:36it can be very overwhelming.
  • 00:38I would encourage all patients
  • 00:40and their support system,
  • 00:41whether that be a family member or
  • 00:44friends to write down any questions
  • 00:46or concerns that they have.
  • 00:48That way you can be sure that these
  • 00:50are addressed during your appointments.
  • 00:52Treatment of plasma cell disorders
  • 00:54is definitely a team approach.
  • 00:56Here at yell at the team is not
  • 00:58only your physician but consist
  • 01:00of an advanced practice provider,
  • 01:03which is a physician assistant.
  • 01:05In our case, practice Tarsis infusion nurses,
  • 01:07nutrition and social work,
  • 01:09which also runs a patient support
  • 01:11group for multiple myeloma patients.
  • 01:13My research focused mirrors
  • 01:14my clinical interest.
  • 01:15I conduct clinical trials in
  • 01:17patients with plasma cell disorders.
  • 01:19There have been many advances in
  • 01:21plasma cell disorders in regards to
  • 01:24the understanding of the diseases,
  • 01:26pathogenesis, and biology.
  • 01:26Which has led to the new developments
  • 01:29of treatments.